newsfilter
← Latest News
GlobeNewswire·

Design Therapeutics to Present at the 2022 Jefferies Cell and Genetic Medicine Summit

CARLSBAD, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (NASDAQ:DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today reported that João Siffert, M.D., president and